Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows
Portfolio Pulse from Jelena Martinovic
A new study by Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY), shows older patients increasingly choosing cannabis for treating chronic pain, arthritis, anxiety, and insomnia. The study, derived from the Canadian Cannabis Patient Survey 2021, included 2,697 patients with a mean age of 54.3. It highlights a significant reduction in the use of prescription opioids among these patients. This research, along with other studies, indicates a growing trend of cannabis consumption among seniors for medical purposes.
April 03, 2024 | 3:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tilray Brands, Inc.'s new study showcases the growing use of cannabis among older patients for treating various ailments, indicating a potential increase in demand for their medical cannabis products.
The study conducted by Tilray Medical, a division of Tilray Brands, Inc., underscores the company's role in the expanding medical cannabis market, particularly among older demographics. This could lead to increased demand for Tilray's medical cannabis products, as the study suggests a growing acceptance and efficacy of cannabis in treating ailments common among older adults. The reduction in prescription opioid use among patients also positions medical cannabis as a viable alternative, potentially broadening Tilray's customer base.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90